Skip to main content
Displaying 1 - 11 of 11
Display:
12
24
48
Immune-Mediated and Cholestatic Diseases
1
BioMarin: Gene therapy clinical trials for haemophilia: A partnership between haematologists and hepatologists - ILC 2022
View
Metabolism, Alcohol & Toxicity
5
IMP: Shining a spotlight on obesity treatment in NAFLD/NASH - ILC 2021
View
Metabolism, Alcohol & Toxicity
5
IMP: Shining a spotlight on obesity treatment in NAFLD/NASH - ILC 2021
View
Metabolism, Alcohol & Toxicity
5
IMP: Shining a spotlight on obesity treatment in NAFLD/NASH - ILC 2021
View
Metabolism, Alcohol & Toxicity
5
IMP: Shining a spotlight on obesity treatment in NAFLD/NASH - ILC 2021
View
Metabolism, Alcohol & Toxicity
5
IMP: Shining a spotlight on obesity treatment in NAFLD/NASH - ILC 2021
View
Metabolism, Alcohol & Toxicity
5
International Medical Press: Obesity management in NAFLD/NASH: can we do more? - Digital ILC 2020
View
Metabolism, Alcohol & Toxicity
5
International Medical Press: Obesity management in NAFLD/NASH: can we do more? - Digital ILC 2020
View
Metabolism, Alcohol & Toxicity
5
International Medical Press: Obesity management in NAFLD/NASH: can we do more? - Digital ILC 2020
View
Metabolism, Alcohol & Toxicity
5
International Medical Press: Obesity management in NAFLD/NASH: can we do more? - Digital ILC 2020
View
Metabolism, Alcohol & Toxicity
5
International Medical Press: Obesity management in NAFLD/NASH: can we do more? - Digital ILC 2020
View
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy